SCHEMBL1021877

SCHEMBL1021877

COC(=O)OC1c2ccc(O)cc2CCN1S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 11/20 0.56
MMP2 P08253 10/20 0.56
MMP9 P14780 10/20 0.56
MMP12 P39900 9/20 0.56
MMP14 P50281 9/20 0.56
MMP15 P51511 9/20 0.56
MMP16 P51512 9/20 0.56
MMP26 Q9NRE1 9/20 0.56
MMP7 P09237 6/20 0.49
TAS2R14 Q9NYV8 1/20 0.45
ADAM17 P78536 1/20 0.44
ESR1 P03372 3/20 0.44
ESR2 Q92731 3/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
MMP13 P45452 1/20 0.42
MMP3 P08254 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1020024 0.93 MMP1 (0.66) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1024879 0.88 MMP1 (0.46) MMP1MMP2MMP9MMP12MMP14
SCHEMBL3534006 0.85 MMP1 (0.66) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1022000 0.85 MEN1 (0.46) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1021326 0.84 ESR1 (0.51) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1020703 0.84 MMP1 (0.43) MMP1MMP2MMP9MMP12MMP14
SCHEMBL5164250 0.83 MMP1 (0.69) MMP1MMP2MMP9MMP12MMP14
SCHEMBL5438666 0.83 MMP1 (0.63) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1019860 0.83 EPHX2 (0.46) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1021485 0.81 CACNA1B (0.43) MMP1MMP2MMP9MMP12MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869001-B1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI AVENTIS (FR) 2011-01-12 EP disclosed
EP-1869001-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE Sanofi-Aventis (FR) 2007-12-26 EP disclosed
WO-2006102998-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI-AVENTIS (DE) 2006-10-05 WO disclosed